959P Combination therapy of envafolimab and suvemcitug in patients with hepatocellular carcinoma (HCC): Results from a phase II clinical trial

Clinical endpoint Progression-free survival Combination therapy
DOI: 10.1016/j.annonc.2023.09.2105 Publication Date: 2023-10-20T12:44:22Z